Ashley Steed, M.D., Ph.D.

Profile picture
Assistant Professor of Pediatrics, Critical Care Medicine
Critical Care MedicinePediatric Research

phone: (314) 454-2527


  • BS, Duke University2001
  • PhD, Washington University in St. Louis2008
  • MD, Washington University in St. Louis2008


  • Residency, Washington University in St. Louis, St. Louis Children's Hospital2008 - 2011
  • Chief Residency, Washington University in St. Louis, St. Louis Children's Hospital2011 - 2012
  • Fellowship, Washington University in St. Louis, St. Louis Children's Hospital2012 - 2016

Licensure and Board Certification

  • 2008 - PresMO, State License
  • 2012 - PresAmerican Board of Pediatrics
  • 2016 - PresBoard Certified, Pediatric Critical Care Medicine

Honors and Awards

  • Phi Eta Sigma1998
  • Annual Merit Award of the National Society of Collegiate Scholars' Chapter at Duke University1999
  • National Society of Collegiate Scholars1999
  • Distinction in Biology Graduate, Duke University2001
  • Honors Thesis: The Role of CLN3 in Batten's Disease and Apoptosis2001
  • Summa Cum Laude Graduate, Duke University2001
  • Elisabeth L. Demonchaux Prize in Pediatrics, Washington University in St. Louis2008
  • Best Basic Science Abstract, Department of Pediatrics Research Retreat2015
  • Teresa Vietti Research Fellow2015
  • Best Fellow Abstract in Continuing Science, Department of Pediatrics Research Retreat2016
  • Fellows Section Basic Research Award, Society for Pediatric Research, Pediatric Academic Society2016
  • David Gilstrap Award2016
  • Burroughs Wellcome Fund Career Award for Medical Scientists2019 - 2024
  • American Society of Clinical Investigation Young Physician-Scientist Award2020
  • Society for Pediatric Research, elected member2022
  • Alpha Omega Alpha, elected member2022

Recent Publications view all (13)

Publication Co-Authors

  1. Severe COVID-19 infection increases both circulating CD14+ monocytes tissue factor (F3 gene) expression and extracellular vesicle phospholipid procoagulant activity Journal of Thrombosis and Haemostasis. 2022. 
  2. Influenza: Toward understanding the immune response in the young Frontiers in Pediatrics. 2022. 
  3. Cell specific peripheral immune responses predict survival in critical COVID-19 patients. Nat Commun. 2022;13(1):882. PMCID:PMC8847593  PMID:35169146 
  4. Early Antibiotic Exposure in Severe Pediatric Traumatic Brain Injury. J Pediatric Infect Dis Soc. 2021. PMID:34555169 
  5. A Case of Severe Combined Immunodeficiency Missed by Newborn Screening. J Clin Immunol. 2021;41(6):1352-1355. PMCID:PMC7954206  PMID:33712943 
  6. Surface Proteins of SARS-CoV-2 Drive Airway Epithelial Cells to Induce IFN-Dependent Inflammation. J Immunol. 2021. PMCID:PMC8278276  PMID:34078711 
  7. Gut microbial dysbiosis after traumatic brain injury modulates the immune response and impairs neurogenesis. Acta Neuropathol Commun. 2021;9(1):40. PMCID:PMC7944629  PMID:33691793 
  8. The Microbial Metabolite Desaminotyrosine Protects from Influenza through Type I Interferon Science. 2017;357(6350):498-502. PMID:28774928 
  9. Role of viruses and bacteria-virus interactions in autoimmunity. Curr Opin Immunol. 2014;31:102-7. PMCID:PMC4254666  PMID:25459001 
  10. Murine gammaherpesvirus 68 has evolved gamma interferon and stat1-repressible promoters for the lytic switch gene 50. J Virol. 2010;84(7):3711-7. PMCID:PMC2838114  PMID:20071569 
  11. Gamma interferon blocks gammaherpesvirus reactivation from latency in a cell type-specific manner. J Virol. 2007;81(11):6134-40. PMCID:PMC1900319  PMID:17360749 
  12. A gamma-herpesvirus deficient in replication establishes chronic infection in vivo and is impervious to restriction by adaptive immune cells. Virology. 2006;353(1):210-9. PMID:16797052 
  13. Gamma interferon blocks gammaherpesvirus reactivation from latency. J Virol. 2006;80(1):192-200. PMCID:PMC1317536  PMID:16352543 
Last updated: 11/10/2022
© 2022 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130